Polmed SA operates in the Specialty outpatient clinics sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Polmed SA with three other
health care providers in Europe:
Institut Simo Milosevic A.D. Igalo
sales of 9.70 million Euro [US$10.42 million]
Vita 34 International Ag
(14.17 million Euro [US$15.22 million]
of which 98%
was Storage from umbilical cord blood), and
Swissmed Centrum Zdrowia SA
(39.59 million Polish New Zlotys [US$9.97 million]
of which 51%
was Medical Services in Ambulatories).
Polmed SA reported sales of 72.86 million Polish New Zlotys (US$18.35 million)
December of 2015.
increase of 19.3%
versus 2014, when the company's sales were 61.08 million Polish New Zlotys.
Sales at Polmed SA have increased during each of the previous five years
(and since 2010, sales have increased a total of 201%).
Sales of Sale of Medical Services saw an increase
19.9% in 2015, from
59.83 million Polish New Zlotys to 71.71 million Polish New Zlotys.
Not all segments of Polmed SA experienced an increase in sales in 2015:
sales of Other Services(Rental) fell 17.9% to 697,000.00 Polish New Zlotys.
(However, this segment's sales were only a very small portion of the company's overall sales).